Joseph Kumka
Board Pearls
Board Pearls is a gastroenterology board review built around clinical reasoning, not recall. Each episode takes one high-yield topic and works it the way you would on rounds: a case to anchor it, the framework that sorts the differential, and the specific decisions the exam rewards. The gastroenterology series covers the full blueprint across nine modules: esophagus, stomach and duodenum, small bowel, colon, pelvic floor, liver, pancreas and biliary, endoscopy, and the cross-cutting topics. Episodes are grouped by chapter and built from the primary guidelines and pivotal trials the boards draw...
Be sure to visit the podcast's website and support the creator: www.boardpearls.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Chapter 26, Ep 3 of 5: Autoimmune Pancreatitis Types One and Two 16.07.2026 7:42
Episode three steps outside the alcohol-and-tobacco gland to a diagnosis that sits at a costly decision point: steroids given to a patient who actually has adenocarcinoma cost the curative resection window. Autoimmune pancreatitis splits on mechanism, type one a systemic IgG4-related plasma-cell disease of older men with painless jaundice, type two a duct-centered process a decade younger tied to...
Chapter 26, Ep 2 of 5: Enzyme Replacement, Type 3c Diabetes, Complications 16.07.2026 13:46
Episode two follows three threads that all trace to the same parenchymal loss the framework episode set up. The acini die and enzyme replacement stands in, but only if dosed with the meal and released at the right duodenal pH, so a proton pump inhibitor enters when the coating fails. The islets die and produce a diabetes defined not by insulin lack but by lost glucagon, which makes hypoglycemia th...
Chapter 26, Ep 1 of 5: Chronic Pancreatitis Framework and Pain 16.07.2026 16:18
Episode one of the Chronic Pancreatitis, Cysts, and Neoplasms chapter builds the framework from a single fact: fewer than three percent of heavy drinkers ever develop the disease, so exposure alone is never enough and a co-modifier has to do the converting. The organizing idea is that tobacco and a genetic background decide who progresses, and where each gene sits in the trypsin-control pathway se...
Chapter 25, Ep 3 of 3: Necrosis, Vascular Traps, and Recurrence 16.07.2026 16:48
Episode three picks up where the pancreas has declared itself necrotic and organizes the collection nomenclature on timing and content. Necrosis is managed by delay, drain, then debride, with endoscopic transmural drainage now favored because it never crosses the peritoneum. The vascular complications split by vessel: venous thrombosis usually self-resolves, while a pseudoaneurysm mandates CT angi...
Chapter 25, Ep 2 of 3: Feeding, ERCP, and the Gallbladder 16.07.2026 9:42
Episode two works through three first-days decisions where the intuitive older instinct turns out to be net harmful. Pancreatic rest with TPN increases infection because an empty lumen lets villi atrophy and gut bacteria translocate into necrotic tissue, so early enteral feeding wins. Universal urgent ERCP was wrong because most triggering stones have already passed, leaving an empty duct and only...
Chapter 25, Ep 1 of 3: Acute Pancreatitis: The First Hours 16.07.2026 15:39
Episode one of the Acute Pancreatitis chapter follows a single mechanism from trypsin escaping its compartment to the cytokine cascade, third-spacing, and lost pancreatic perfusion. The organizing idea: every first-hours decision reaches back to that mechanism. The two-of-three rule diagnoses around the failure modes of pain, enzymes, and imaging alone; the cause is worked up on admission because...
Chapter 24, Ep 4 of 4: Liver Transplant Scoring to Recurrence 16.07.2026 18:02
Episode four follows a patient across the whole transplant arc, organized by two clocks: the allocation score that triages who is sickest, and time itself, which orders both the drop in immunosuppression intensity and the shift from acute risk to cumulative toxicity. The calculated score does the primary triage with its sex and albumin corrections fixing real undervaluation, the workup confirms th...
Chapter 24, Ep 3 of 4: Cholangiocarcinoma by Anatomy 16.07.2026 10:44
Episode three organizes cholangiocarcinoma anatomy first, biology second, because where the tumor sits dictates the operation and the transplant path. Intrahepatic disease is resected when possible and is a transplant contraindication over two centimeters, distal disease gets a Whipple, and perihilar disease is resected when resectable with a narrow unresectable subset going through a neoadjuvant-...
Chapter 24, Ep 2 of 4: Hepatocellular Carcinoma End to End 16.07.2026 12:30
Episode two works hepatocellular carcinoma as one continuous algorithm built on a single override: a new lesion in a cirrhotic or chronic hepatitis B liver is HCC until proven otherwise. Surveillance goes to every Child-Pugh A or B cirrhotic and to high-risk hepatitis B, by ultrasound and AFP every six months timed to the tumor doubling time and the curative-size cutoffs. LI-RADS turns that findin...
Chapter 24, Ep 1 of 4: Benign Liver Lesions by Context 16.07.2026 6:47
Episode one of the Liver Tumors and Transplant chapter runs the benign masses on a single decision: imaging appearance plus hormonal or drug context usually settles the diagnosis, and biopsy enters only when the imaging is atypical or the lesion has real malignant potential. Peripheral nodular enhancement filling inward is a hemangioma, hepatobiliary-phase retention is focal nodular hyperplasia, a...
Chapter 23, Ep 3 of 3: Pulmonary, Coagulopathy, and Vascular Complications 16.07.2026 16:28
Episode three covers the decompensated complications that do not flow primarily through splanchnic vasodilation, starting with two pulmonary syndromes that look related but are physiologically opposite. Hepatopulmonary syndrome is capillary dilation with shunt physiology, recognized by platypnea and orthodeoxia, while portopulmonary hypertension is arteriolar constriction diagnosed by right heart...
Chapter 23, Ep 2 of 3: The Splanchnic Vasodilation Cluster 16.07.2026 18:11
Episode two follows the splanchnic vasodilation cluster, where one upstream physiology produces four complications, each with its own bundle, threshold, and drug sequence. Portal hypertension drives splanchnic vasodilation, the kidney reads effective hypovolemia and retains sodium, and from that single mismatch flow ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, and hepatic ence...
Chapter 23, Ep 1 of 3: Portal Hypertension and Varices 16.07.2026 15:07
Episode one of the Portal Hypertension and Cirrhosis Complications chapter treats portal hypertension as a pressure problem first, then follows that pressure into varices and bleeding. The organizing idea: the hepatic venous pressure gradient is the hemodynamic gold standard, and liver stiffness plus platelets give the noninvasive translation that now drives beta-blocker and screening decisions. S...
Chapter 22, Ep 3 of 3: A1AT, CF Liver Disease, PCLD, and Cholestatic Syndromes 16.07.2026 15:48
Episode three closes the chapter with the four inherited liver diseases beyond the metal pair: alpha-one antitrypsin deficiency, cystic-fibrosis-associated liver disease, polycystic liver disease, and the familial cholestatic syndromes. The unifying move is that mechanism predicts therapy in each one, and each carries a distinct board trap. Alpha-one antitrypsin is the two-organ split where augmen...
Chapter 22, Ep 2 of 3: Wilson Disease 16.07.2026 9:46
Episode two takes the other metal-handling disease, Wilson, where the toxin is copper and the ATP7B pump fails at two coupled jobs: pushing copper into bile and loading it onto ceruloplasmin. The diagnostic logic is harder because no single test stands alone, so the Leipzig score integrates weighted features and the chelator choice turns on the speed and site of copper movement. Low ceruloplasmin,...
Chapter 22, Ep 1 of 3: Hereditary Hemochromatosis 16.07.2026 9:38
Episode one of the Inherited Liver Diseases chapter takes hereditary hemochromatosis and reasons from the molecular lesion outward: lose the HFE signal, lose the hepcidin brake, and iron pours in unchecked for decades. The organizing move is that genotype alone is a substrate, not a disease, so diagnosis rests on biochemistry plus genotype, not a positive C282Y result by itself. Iron regulation, t...
Chapter 21, Ep 2 of 2: Alcohol-Associated Liver Disease and Early Transplant 16.07.2026 11:54
Episode two moves along the alcohol continuum to alcohol-associated liver disease, one biology read across steatosis, steatohepatitis, and cirrhosis, then zeroes in on the acute superimposed syndrome of severe alcoholic hepatitis. The organizing idea: severe disease is defined by a Maddrey above thirty-two or a MELD over twenty, treated with prednisolone only after infection is excluded, with the...
Chapter 21, Ep 1 of 2: MASLD: Diagnosis Through Pharmacotherapy 16.07.2026 16:58
Episode one of the Steatotic Liver Disease chapter reframes fatty liver as MASLD, a positive diagnosis built on hepatic steatosis plus at least one of five cardiometabolic criteria rather than an exclusion. The organizing idea: fibrosis stage, not the transaminase or the degree of steatosis, is the prognostic anchor, so the workup runs a tiered noninvasive sequence and management is graded by how...
Chapter 20, Ep 3 of 3: Primary Sclerosing Cholangitis and IgG4 Disease 16.07.2026 15:25
Episode three works primary sclerosing cholangitis, the multifocal stricturing disease of the man with ulcerative colitis, as a recognition-and-surveillance problem, then covers its steroid-responsive mimic. MRCP not serology makes the diagnosis, the alkaline phosphatase is normal in nearly half of patients at any moment, and because there is no proven medical therapy the work is surveillance for...
Chapter 20, Ep 2 of 3: Primary Biliary Cholangitis 16.07.2026 11:52
Episode two works primary biliary cholangitis, the anti-mitochondrial-antibody cholestatic disease of the middle-aged woman, as a biochemical-target-driven problem. The diagnosis is usually made on labs alone, treatment starts with ursodeoxycholic acid for everyone, and escalation is driven by where the alkaline phosphatase and bilirubin sit at twelve months, because those numbers are the surrogat...
Chapter 20, Ep 1 of 3: Sorting the Immune Liver Diseases and Autoimmune Hepatitis 16.07.2026 11:13
Episode one of the Autoimmune and Cholestatic Liver Diseases chapter builds the sorting framework for the three immune liver diseases and then works autoimmune hepatitis in depth. The organizing idea: pattern plus demographics plus antibodies place a patient into autoimmune hepatitis, primary biliary cholangitis, or primary sclerosing cholangitis within the first two sentences of the vignette. Aut...
Chapter 19, Ep 2 of 2: Acute Liver Failure and the King's College Criteria 16.07.2026 16:14
Episode two shifts from the drug to the failing organ, asking whether the liver can still recover on its own, how much time you have to decide, and when a different liver is the only answer. It anchors on the four-criterion definition of acute liver failure, then shows how etiology maps directly to the probability of spontaneous recovery. Two special causes, Wilsonian and herpes acute liver failur...
Chapter 19, Ep 1 of 2: Drug-Induced Liver Injury and Acetaminophen 16.07.2026 21:56
Episode one of the Drug-Induced Liver Injury and Acute Liver Failure chapter builds drug injury from a single mechanism: cytochrome oxidation makes a reactive intermediate, phase-two conjugation quenches it or fails, and injury appears where phase one outpaces phase two. That frame makes the offender lists predictable, the histology readable, and the severity rules non-arbitrary. Hy's Law converts...
Chapter 18, Ep 3 of 3: Hepatitis C 16.07.2026 14:12
Episode three covers hepatitis C, now a curable disease, and tests the entire workflow of cure: identify the virus, confirm replication, stage the liver, pick the regimen, document cure, then ask the one remaining cancer question. It runs the reflex antibody-then-RNA diagnosis, the two pangenotypic direct-acting antiviral regimens plus the salvage regimen, and a special-populations set built on a...
Chapter 18, Ep 2 of 3: Hepatitis B and D 16.07.2026 17:11
Episode two steps inside hepatitis B, where the serologic panel is not just diagnostic but a phase grid that determines treatment, the pregnancy strategy, the reactivation rule, and the hepatitis D testing decision. It reads two grids: the serologic grid of surface antigen, core antibody, and surface antibody that places the patient, and the phase grid of e-antigen, DNA, and ALT that decides wheth...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.